EC-70124 structure
|
Common Name | EC-70124 | ||
---|---|---|---|---|
CAS Number | 1185908-92-2 | Molecular Weight | 453.454 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H19N3O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of EC-70124EC-70124 is a multikinase inhibitor with potent activity against several AML related kinases including FLT3, JAK, SYK or Pim kinases (Kd<10 nM); inhibits 7 out of 9 FLT3 mutants, also acts as a dual STAT3/NF-kB inhibitor, reverting both tumorigenic and stem cell properties in prostate cancer; inhibits AML cell proliferation and induces cell cycle arrest and apoptosis; in vivo oral treatment causes complete regression in AML tumor xenograft models, and ex vivo inhibits proliferation in AML patient blasts at biochemically relevant doses. |
Name | EC-70124 |
---|
Description | EC-70124 is a multikinase inhibitor with potent activity against several AML related kinases including FLT3, JAK, SYK or Pim kinases (Kd<10 nM); inhibits 7 out of 9 FLT3 mutants, also acts as a dual STAT3/NF-kB inhibitor, reverting both tumorigenic and stem cell properties in prostate cancer; inhibits AML cell proliferation and induces cell cycle arrest and apoptosis; in vivo oral treatment causes complete regression in AML tumor xenograft models, and ex vivo inhibits proliferation in AML patient blasts at biochemically relevant doses. |
---|---|
References | References 1. Civenni G, et al. Mol Cancer Ther. 2016 May;15(5):806-18. 2. Cuenca-López MD, et al. Oncotarget. 2015 Sep 29;6(29):27923-37. 3. Puente-Moncada N, et al. 4. Sánchez C, et al. Chem Commun (Camb). 2009 Jul 21;(27):4118-20. View Related Products by Target FLT3 |
Molecular Formula | C26H19N3O5 |
---|---|
Molecular Weight | 453.454 |